The French drugmaker said that the investment of about 1 billion euros will enhance the production and manufacturing of ...

Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

SHANGHAI, Dec 2 (Reuters) - Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production ...

Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal ...

Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 ...

Sanofi has made its single largest investment in China to date by pouring roughly €1 billion ($1.05 billion) into a new ...

French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in ...